Literature DB >> 56538

Dopamine acetylcholine imbalance in Parkinson's disease. Possible regenerative overgrowth of cholinergic axon terminals.

R Spehlmann, S M Stahl.   

Abstract

Parkinson's disease is characterised by an imbalance between acetylcholine and dopamine which probably results from the degeneration of a dopaminergic nigrostriatal pathway. A new hypothesis is proposed to explain the development of this imbalance. Applying the concept that degeneration of nerve-fibres in the central nervous system can lead to collateral sprouting of uninjured fibres, it is suggested that the death of dopaminergic nigrostriatal neurons results in sprouting of axons of cholinergic interneurons in the caudate nucleus. This overgrowth could result in the cholinergic innervation of neuronal membranes vacated by degenerated dopaminergic terminals. Thus, the apparent changes in the activity of dopaminergic and cholinergic systems can be accounted for by faulty regeneration in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56538     DOI: 10.1016/s0140-6736(76)93095-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

Review 1.  The biochemistry of the basal ganglia and Parkinson's disease.

Authors:  G Curzon
Journal:  Postgrad Med J       Date:  1977-12       Impact factor: 2.401

2.  Evidence for a change in neurotransmitter affecting oesophageal motility in Parkinson's disease.

Authors:  M G Bramble; J Cunliffe; A W Dellipiani
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-08       Impact factor: 10.154

3.  Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson's Disease.

Authors:  Jonathan W McKinley; Ziqing Shi; Ivana Kawikova; Matthew Hur; Ian J Bamford; Suma Priya Sudarsana Devi; Annie Vahedipour; Martin Darvas; Nigel S Bamford
Journal:  Neuron       Date:  2019-07-16       Impact factor: 17.173

Review 4.  Aetiology and natural history of Parkinson's disease.

Authors:  J M Pearce
Journal:  Br Med J       Date:  1978-12-16

5.  A role of the polysynaptic system of substantia nigra in the cholinergic-dopaminergic equilibrium in the central nervous system.

Authors:  S Wolfarth; E Dulska; K Gołembiowska-Nikitin; J Vetulani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-04       Impact factor: 3.000

6.  Real-world pharmacological treatment patterns of patients with young-onset Parkinson's disease in Japan: a medical claims database analysis.

Authors:  Sachiko Kasamo; Masato Takeuchi; Masashi Ikuno; Yohei Kawasaki; Shiro Tanaka; Ryosuke Takahashi; Koji Kawakami
Journal:  J Neurol       Date:  2019-05-10       Impact factor: 4.849

Review 7.  Localising movement disorders in childhood.

Authors:  Nigel S Bamford; Kathryn McVicar
Journal:  Lancet Child Adolesc Health       Date:  2019-10-22

8.  Frontal GABA levels change during working memory.

Authors:  Lars Michels; Ernst Martin; Peter Klaver; Richard Edden; Fernando Zelaya; David J Lythgoe; Rafael Lüchinger; Daniel Brandeis; Ruth L O'Gorman
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

9.  A network model of basal ganglia for understanding the roles of dopamine and serotonin in reward-punishment-risk based decision making.

Authors:  Pragathi P Balasubramani; V Srinivasa Chakravarthy; Balaraman Ravindran; Ahmed A Moustafa
Journal:  Front Comput Neurosci       Date:  2015-06-17       Impact factor: 2.380

10.  Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson's Disease.

Authors:  Kyu Hwan Shim; Han Gyeol Go; Heewon Bae; Da-Eun Jeong; Danyeong Kim; Young Chul Youn; SangYun Kim; Seong Soo A An; Min Ju Kang
Journal:  Front Aging Neurosci       Date:  2021-05-28       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.